Infectious Diseases News

LOS ANGELES--(BUSINESS WIRE)--The Chan Soon-Shiong Family Foundation today announced a $10 million commitment to the Africa Centres for Disease Control and Prevention (Africa CDC) and other non-profit organizations supporting the urgent response to the active outbreak of Bundibugyo Ebola Disease in the Democratic Republic of the Congo (DRC), which has now spread to Uganda. The grant will support critical response efforts, including disease surveillance, contact tracing, case management, laborat...

FOSTER CITY, Calif., & RAHWAY, N.J.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the primary efficacy endpoint at Week 48 was met in both the Phase 3 ISLEND-1 and ISLEND-2 trials with the investigational oral once-weekly single-tablet HIV treatment regimen of islatravir/lenacapavir. The ISLEND trials are evaluating the efficacy and safety of islatravir 2 mg/lenacapavir 300 mg (ISL/LEN) in...

RAICHUR, India & BARCELONA, Spain--(BUSINESS WIRE)--Shilpa Medicare Ltd has entered a strategic equity partnership with Gate2Brain, S.L., a biotechnology company focused on CNS therapeutics....

BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 (the “Annual Report”) with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed at the Company's website at www.sinovac.com.cn or www.sinovac.com and at the SEC’s website www.sec.gov. The Company also...

LOS ANGELES--(BUSINESS WIRE)--AHF's ‘GOOOOOOOOOAL!’ Billboards Remind World Cup Fans to Score Safely...

CHICAGO--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) filed a lawsuit against the City of Chicago, Department of Public Health (CDPH) over its handling of the administration and award of program funds under two of its 2026 Ryan White HIV/AIDS Program Requests for Proposals (RFP), which defunded many organizations including AHF that provide care and treatment to people living with HIV in the Chicagoland area. The cuts disenfranchise hundreds of Chicago patients and clients from accessing th...

SAN FRANCISCO--(BUSINESS WIRE)--The Quantitative Biosciences Institute (QBI) at the University of California, San Francisco (UCSF) today announced the appointment of Andy Kilianski, Ph.D., as Chief Science and Technology Officer. Dr. Kilianski brings over a decade of distinguished experience spanning academic virology, national security, and translational research leadership, making him uniquely positioned to advance QBI’s mission of translating cutting-edge integrative science into transformat...

AUSTIN, Texas & VANCOUVER, Wash.--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, and CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, today announced a strategic collaboration to evaluate circulating tumor DNA (ctDNA) dynamics and generate real-world molecular insi...

BOSTON--(BUSINESS WIRE)--Rapid diagnostic clarity enables targeted treatment while avoiding neurosurgery benefiting patients....

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX) a clinical-stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform, today announced positive results from two studies evaluating the Company’s oral CPSF3 inhibitor, AN2-502998, for the treatment of chronic Chagas disease (American trypanosomiasis) caused by infection with the parasite T. cruzi. Key findings from the two studies: In NHPs with naturally acquire...